CS
BMRN icon

Credential Securities’s BioMarin Pharmaceuticals BMRN Stock Holding History

Credential Securities’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$230K Buy
2,445
+148
+6% +$13K 0.05% 158
2018
Q1 		$186K Buy
2,297
+6
+0.3% +$515 0.04% 169
2017
Q4 		$204K Sell
2,291
-5
-0.2% -$435 0.05% 168
2017
Q3 		$214K Sell
2,296
-74
-3% -$6.54K 0.06% 168
2017
Q2 		$213K Buy
2,370
+623
+36% +$56.7K 0.07% 169
2017
Q1 		$153K Buy
+1,747
New +$155K 0.05% 174

Other funds holding BMRN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Credential Securities's BMRN Position: Q2 2018 in Review

Credential Securities increased its BioMarin Pharmaceuticals (BMRN) stake by 6.4% in Q2 2018, buying an estimated $13K and bringing the position to 2,445 shares worth $230K. The position accounts for 0.05% of the portfolio, ranked #158.

Credential Securities first reported a position in BMRN in Q1 2017 and has held it in 6 quarters since. 449 funds tracked by Wall St. Rank hold BMRN as of Q2 2018.

  • Credential Securities held 2,445 shares of BioMarin Pharmaceuticals worth $230K as of Q2 2018.
  • Credential Securities bought 148 BioMarin Pharmaceuticals shares in Q2 2018, an estimated $13K.
  • BioMarin Pharmaceuticals made up 0.05% of Credential Securities's portfolio in Q2 2018, its #158 holding.
  • Credential Securities first reported a position in BioMarin Pharmaceuticals in Q1 2017 and has held it in 6 quarters since.
  • 449 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2018.

Based on Credential Securities's 13F filing for Q2 2018, filed 21 Jul 2025.